1. Core Principles of PLLA: What Exactly Is a Medical-Grade Regenerative Polymer?
PLLA stands for poly-L-lactic acid. It is derived from natural crops such as corn and sugarcane, from which starch is extracted and fermented by microorganisms to produce high-purity L-lactic acid. This is then polymerized via a precisely controlled ring-opening polymerization process to form a regular-structured, uniform molecular weight, stable-performance left-handed polymer. The entire process is petroleum-independent, low-pollution, and high-purity, making PLLA a truly “nature-derived, human-body-compatible, residue-free metabolizable” green medical material.
2.Full-Scenario Applications: Empowering Multiple High-End uses
- Regenerative Aesthetics & Anti-Aging: Core Raw Material for Natural, Long-Lasting Collagen Regeneration
PLLA microspheres are the core ingredient used in biostimulatory dermal filler products such as PLLA (Poly-L-lactic acid) collagen-stimulating injectable filler,facial contouring injectable fillers,precision anti-aging formulation for neck lines and periorbital rejuvenation.
Aesthetics Dermal Fillers Matching PLLA Specifications and Viscosity Requirements
Matching PLLA Type Particle Size Intrinsic viscosity (IV) Other Parameter
General use 30-60um 1.0–1.5 dL/g 1.Weight average molecular weight (Mw) = 120,000–180,000 Da
2.Crystallinity 35%–42%;
Refined filler for periorbital/thin‑skin areas 20-40um 0.9–1.2 dL/g 3.Sphericity ≥0.95
Long‑lasting contouring filler (jawline, temples) 40-60um 1.3–1.6 dL/g 4. free from ultrafine fines and agglomeration.
- Biomedical Field: Long-Acting Targeted Drug Delivery Carriers
Application Products:
Medical-grade PLLA can also be processed into nano- and micron-sized microspheres and microcapsules, serving as excellent carriers for peptides, proteins, anti-inflammatory drugs, anticancer agents, and various other pharmaceuticals. Leveraging its controllable degradation properties, it enables targeted drug delivery and long-term sustained release, precisely acting on lesion sites. This significantly reduces drug toxicity and side effects, decreases dosing frequency, and improves drug utilization and patient compliance. It is widely used in the R&D and production of long-acting formulations and implantable drug delivery systems.
Matching PLLA Specifications and Viscosity Requirements
| Matching PLLA Type | Release period | Intrinsic viscosity (IV) | Molecular Weight | Feature |
|---|---|---|---|---|
| Short-term sustained release | 1-3 months | 0.4–0.8 dL/g | 40,000–100,000 | Crystallinity 25%–32% controllable porosity, enabling rapid erosion and drug release |
| Medium-term sustained release | 3-12 months | 0.9–1.4 dL/g | 110,000–170,000 | Uniform degradation to avoid burst release |
| Long-term implantable delivery | >12 months | 1.6–2.2 dL/g | 200,000–300,000 | High crystallinity, slow bulk degradation, long-term steady drug release |
Material Property Matching Logic
Viscosity and molecular weight directly modulate the degradation rate and drug release kinetics. Low viscosity, low molecular weight PLLA exhibits higher porosity and faster degradation, making it suitable for short‑term delivery; high‑viscosity, high‑molecular‑weight PLLA has a denser chain structure, which slows degradation and fits long‑term sustained release. Customizable nano and micro scale particle sizes enable targeted accumulation at the lesion site, significantly reducing drug toxicity and side effects, decreasing dosing frequency, and improving drug utilization and patient compliance.
- High-end Skincare: Dual Action of Physical Skin Smoothing + Biological Skin Renewal
High-purity PLLA microspheres can be added to serums, creams, and repair products as a high-end anti-aging skincare ingredient. On one hand, PLLA microspheres physically smooth skin texture and improve roughness; on the other hand, they gently stimulate superficial collagen regeneration, repair damaged barriers, reduce fine lines, and firm the skin. The material is mild, non-irritating, and naturally metabolizable, making it suitable for developing high-performance functional skincare products.
Application Products:
Anti‑aging serum, firming cream, repairing mask, and professional‑use rejuvenating concentrate.
Matching PLLA Specifications and Viscosity Requirements
Matching PLLA Type Particle Size Intrinsic viscosity (IV) Molecular weight (Mw)
Ultrafine PLLA Microspheres ≤30um(10-25um) 0.8–1.2 dL/g 90,000–150,000
- Absorbable Medical Consumables: Avoiding Secondary Trauma
With its safe biodegradability and excellent toughness, PLLA can be manufactured into absorbable surgical sutures, wound-healing membranes, and medical dressing substrates. Post-surgery, there is no need for suture removal or material retrieval, effectively preventing secondary trauma and reducing infection risk. It is widely applied in surgical, dermatological, and minimally invasive clinical settings.
Matching PLLA Specifications and Viscosity Requirements
Application Matching PLLA Type Particle Size Intrinsic viscosity (IV) Crystallinity Molecular weight (Mw) Feature
Absorbable sutures High-viscosity, spinning-grade PLLA / 1.8–2.5 dL/g 40%–48% 250,000–380,000 High tensile strength and excellent toughness
Wound films/ dressing films Medium-viscosity, film-forming grade PLLA / 1.2–1.8 dL/g / 50,000–240,000 uniform film formation, flexibility, and good conformity to wound surfaces
Short-term repair with superficial dressings Low-viscosity modified PLLA powder / 0.7–1.1 dL/g / 90,000–150,000 enabling rapid degradation and suitable for short-term repair of superficial wounds.
Material Property Matching Logic
High viscosity, high molecular weight PLLA possesses longer polymer chains, yielding outstanding tensile mechanical strength that meets the tensile requirements for sutures. The medium viscosity grade is easily cast into films and conforms well to skin wounds. Postoperatively, there is no need for secondary suture removal or device retrieval, effectively avoiding secondary trauma and reducing the risk of surgical site infection. These materials are widely used in surgery, dermatology, minimally invasive procedures, and other clinical settings.
- Orthopedic Implants & Tissue Engineering: Core Material for Regenerative Repair
The excellent mechanical support properties of PLLA allow it to be fabricated into absorbable bone screws, bone fixation plates, soft-tissue repair scaffolds, and other implantable devices. After implantation, these degrade in tandem with bone and tissue healing, significantly reducing surgical risks and medical costs. Additionally, customizable three-dimensional porous scaffolds provide a biomimetic environment for cell adhesion and proliferation, aiding the regeneration and repair of skin, bone, and soft tissues—making PLLA a core material in regenerative medicine research and industrialization.
Matching PLLA Specifications and Viscosity Requirements
Application Matching PLLA Type Particle Size Intrinsic viscosity (IV) Crystallinity Molecular weight (Mw) Feature
Load-bearing orthopedic implants (bone screws/bone fixation plates) Ultra-high-viscosity, injection-molding grade PLLA / 2.6–3.5 dL/g 45%–52% 400,000–600,000 Excellent flexural and compressive mechanical properties
Non-load-bearing soft tissue porous scaffolds Medium-to-high-viscosity, foaming grade PLLA / 1.5–2.4 dL/g / 180,000–350,000 Easy to prepare into three-dimensional porous structures with good cell affinity
3D-printed tissue scaffolds Controlled-viscosity PLLA powder / 1.4–2.2 dL/g / 90,000–150,000 With a stable melting range to ensure warp free printing and molding
Material Property Matching Logic
The ultra high viscosity and ultra high molecular weight provide strong mechanical support, enabling PLLA to serve as a temporary substitute for metal internal fixation devices, while degrading slowly and synchronously with bone healing. The medium to high viscosity grades are ideal for fabricating porous biomimetic scaffolds, which create a favorable microenvironment for cell adhesion and proliferation, thereby promoting the regeneration and repair of skin, bone, and soft tissues. This makes PLLA a core material for both research and industrialization in regenerative medicine.
EPRUI also support full-category customization and deep processing of aesthetic microspheres, including hydroxyapatite (CaHA), PMMA, PCL, PLGA, and other series, to fully accommodate clients’ diverse R&D and production needs.